| dc.contributor.author | Bebawy Mary | en_US |
| dc.contributor.author | Morris M B | en_US |
| dc.contributor.author | Roufogalis Basil | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-02-02T05:35:35Z | |
| dc.date.available | 2012-02-02T05:35:35Z | |
| dc.date.issued | 1999 | en_US |
| dc.identifier | 2010004309 | en_US |
| dc.identifier.citation | Bebawy Mary, Morris M B, and Roufogalis Basil 1999, 'A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles', Academic Press Inc, vol. 268, no. 2, pp. 270-277. | en_US |
| dc.identifier.issn | 0003-2697 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/14662 | |
| dc.description.abstract | A fluorimetric procedure for assaying the transport activity of P-glycoprotein (P-gp) using a membrane vesicle model has been developed. In this assay methylene blue is incorporated into inside-out vesicles prepared from human acute lymphoblastic leukemic cells resistant to 100 ng z ml21 vinblastine (VBL100) and their sensitive controls. The fluorescence of a fluorescent derivative of colchicine (fluorescein¿colchicine) is quenched as the probe is transported across the vesicle membrane. The fluorescein¿colchicine transport was found to be dependent on the presence of P-glycoprotein, required ATP, and was inhibited by vanadate and the reversal agent, verapamil, in a dose-dependent manner. Furthermore, the transport was competed against by the P-gp substrates, vinblastine and methotrexate. The transport of fluorescein¿colchicine by P-gp was found to be cooperative (n 5 1.23). | en_US |
| dc.language | en_US | |
| dc.publisher | Academic Press Inc | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1006/abio.1998.3087 | en_US |
| dc.title | A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles | en_US |
| dc.parent | Analytical Biochemistry | en_US |
| dc.journal.volume | 268 | en_US |
| dc.journal.number | 2 | en_US |
| dc.publocation | San Diego | en_US |
| dc.identifier.startpage | 270 | en_US |
| dc.identifier.endpage | 277 | en_US |
| dc.cauo.name | GSH.Pharmacy | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 030100 | en_US |
| dc.personcode | 112474;0000069522;X000240 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Analytical Chemistry | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | WOS:000079508100014 | en_US |
| dc.description.keywords | fluorescein¿colchicine; multidrug resistance; P-glycoprotein substrates; methylene blue; inside-out membrane vesicle | en_US |
| dc.staffid | University of Sydney | en_US |